Detalhe da pesquisa
1.
Chronic Hepatitis C Related Steatotic Liver Disease Is More Than "Miscellaneous Steatotic Liver Disease".
Clin Gastroenterol Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729391
2.
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
Clin Gastroenterol Hepatol
; 22(6): 1275-1285.e2, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365094
3.
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Clin Gastroenterol Hepatol
; 22(3): 572-580.e5, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734582
4.
Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
Am J Gastroenterol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534155
5.
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma.
J Transl Med
; 22(1): 268, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38475805
6.
The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic area.
J Gastroenterol Hepatol
; 39(1): 193-201, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731071
7.
Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver disease.
J Gastroenterol Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38725327
8.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480009
9.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208843
10.
Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 21(4): 960-969.e1, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124270
11.
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients.
Clin Gastroenterol Hepatol
; 21(4): 1013-1022.e6, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654298
12.
Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort.
Virol J
; 20(1): 112, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268999
13.
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes.
J Formos Med Assoc
; 122(3): 202-220, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750398
14.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333150
15.
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
Liver Int
; 42(1): 59-68, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687130
16.
A Pilot First-in-Human Study of Embrace, a Polyethylene Glycol-Based Liquid Embolic Agent, in the Embolization of Malignant and Benign Hypervascular Tumors.
J Vasc Interv Radiol
; 33(6): 660-667, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278638
17.
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
J Gastroenterol Hepatol
; 37(10): 1901-1910, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790343
18.
Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021.
J Formos Med Assoc
; 121(9): 1767-1772, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35067428
19.
Body weight changes in treated hepatitis B patients switching to tenofovir alafenamideâ.
J Formos Med Assoc
; 121(7): 1273-1282, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625346
20.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
J Formos Med Assoc
; 121(8): 1567-1578, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123849